142 related articles for article (PubMed ID: 3871382)
21. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Philippon A
Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
[TBL] [Abstract][Full Text] [Related]
22. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
23. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Monteil H; Peladan F; Zinsius M
Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
[TBL] [Abstract][Full Text] [Related]
24. A microbiological evaluation of apalcillin.
Wiedemann B; Seeberg A
Infection; 1983; 11(6):340-4. PubMed ID: 6421745
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
[TBL] [Abstract][Full Text] [Related]
26. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
[TBL] [Abstract][Full Text] [Related]
27. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
28. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
Verbist L
Antimicrob Agents Chemother; 1979 Aug; 16(2):115-9. PubMed ID: 485123
[TBL] [Abstract][Full Text] [Related]
30. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].
Soussy CJ; Duval J; Chanal M; Sirot D; Bergogne-Bérézin E; Joly-Guillou ML; Malbruny B; Morel C
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743
[TBL] [Abstract][Full Text] [Related]
31. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
Sobel JD; Levison ME; Kaye D
Infection; 1980; 8(3):121-2. PubMed ID: 6448229
[TBL] [Abstract][Full Text] [Related]
32. Azlocillin and mezlocillin: new ureido penicillins.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1978 Jun; 13(6):930-8. PubMed ID: 677860
[TBL] [Abstract][Full Text] [Related]
33. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
34. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
[TBL] [Abstract][Full Text] [Related]
35. The penicillins.
Wright AJ; Wilkowske CJ
Mayo Clin Proc; 1991 Oct; 66(10):1047-63. PubMed ID: 1921489
[TBL] [Abstract][Full Text] [Related]
36. Comparative activity of newer antibiotics against gram-negative bacilli.
Knapp CC; Washington JA
Cleve Clin J Med; 1989; 56(2):161-6. PubMed ID: 2731335
[TBL] [Abstract][Full Text] [Related]
37. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
Gootz TD; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
[TBL] [Abstract][Full Text] [Related]
40. Azlocillin: in vitro studies of a new semisynthetic penicillin.
Stewart D; Bodey GP
Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
